Title : Entacapone and prostate cancer risk in patients with Parkinson's disease.

Pub. Date : 2015 Apr 15

PMID : 25639262






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the STRIDE-PD study, prostate cancer developed in 9 patients (3.7%) receiving levodopa/carbidopa with entacapone, a catechol-O-methyltransferase inhibitor, versus 2 cases (0.9%) without entacapone. entacapone catechol-O-methyltransferase Homo sapiens